Form 4: Compass Pathways Director Malievskaia Reports Stock Sales Under 10b5-1 Plan
SEC Form 4 Filing
Ekaterina Malievskaia, a director at Compass Pathways, reported the sale of ordinary shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Ekaterina Malievskaia, a director of Compass Pathways plc, reported the sale of 25,750 ordinary shares on April 1, 2024, at a weighted average price of $8.9579.
- These sales were executed automatically under a Rule 10b5-1 trading plan adopted on August 23, 2023.
- Following the transaction, Dr. Malievskaia directly owns 4,008,130 ordinary shares.
- An additional 25,750 shares were sold on the same date, with her spouse indirectly owning 4,010,404 shares.
- Dr. Malievskaia and her spouse disclaim beneficial ownership of each other's shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock sales by a company director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Sales by company directors are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on inside information.
Key Dates
| Date | Description |
|---|---|
| 2023/08/23 | Rule 10b5-1 trading plan adopted by Dr. Malievskaia and Mr. Goldsmith |
| 2024/04/01 | Date of transaction: Sale of ordinary shares |
| 2024/04/02 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.